The Cannabist Co. will sell its vertically integrated permit in Virginia to a Boston-based hedge fund rather than competing MSO Curaleaf.

Marijuana rescheduling isn't official yet. Here's what needs to happen for cannabis to be downgraded under federal law.

The U.S. cannabis industry continued to pullback in the third quarter of 2025, according to licensing data from intelligence ...

A partnership between High Times and Hoodie Analytics gives retailers and brands increased visibility on the publication’s ...

Cannabis will be moved to Schedule 3 of the Controlled Substances Act under an executive order President Donald Trump signed Thursday.

President Donald Trump's order to reclassify cannabis as a Schedule 3 drug is a huge step forward - but operators must know its limits.

If the reaction from conservative pundits and MAGA world figures is any indication, President Donald Trump will reclassify ...

Cannabis MSO PharmaCann is selling some of its Colorado retail assets to Vireo Growth Inc. for $49 million in newly issued ...

New Jersey legislators are moving forward with a bill that could reshape the state’s market for hemp-derived cannabinoids.

The Maine cannabis industry would become medical-only - and with strict new rules - if a ballot initiative campaign is successful.

Cannabis prices are falling in Connecticut but still remain double bordering Massachusetts. Overall sales are also declining, data shows.

Prominent right-wing media figures and lawmakers alike sounded the alarm over President Donald Trump's consideration of marijuana rescheduling. A ballot initiative that would end the Maine adult-use ...